Gene Symbol | Gene ID | Gene Info |
---|---|---|
Alx4
|
ENSMUSG00000040310.6 | aristaless-like homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_93642502_93642662 | Alx4 | 194 | 0.959910 | 0.37 | 5.7e-03 | Click! |
chr2_93662426_93662770 | Alx4 | 20210 | 0.205469 | -0.36 | 7.1e-03 | Click! |
chr2_93642067_93642218 | Alx4 | 242 | 0.946989 | 0.35 | 7.9e-03 | Click! |
chr2_93666598_93666749 | Alx4 | 24285 | 0.192597 | 0.25 | 6.9e-02 | Click! |
chr2_93625118_93625505 | Alx4 | 17073 | 0.230005 | -0.16 | 2.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_11927079_11927230 | 29.32 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
81944 |
0.1 |
chr12_51002047_51002408 | 29.00 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr13_99444397_99444879 | 28.16 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr2_106512677_106513062 | 27.92 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr11_112501711_112502406 | 26.67 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr12_4220043_4220458 | 26.36 |
Gm48210 |
predicted gene, 48210 |
1852 |
0.19 |
chr4_24429061_24429567 | 25.64 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr13_83750227_83750397 | 25.08 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chrX_166344291_166344543 | 24.62 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr6_54552680_54553127 | 24.15 |
Scrn1 |
secernin 1 |
1543 |
0.37 |
chr1_96346717_96347057 | 23.06 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chrX_169838405_169838582 | 22.73 |
Mid1 |
midline 1 |
10334 |
0.25 |
chr11_43270024_43270232 | 22.00 |
Gm12146 |
predicted gene 12146 |
10344 |
0.19 |
chr9_66933818_66934187 | 21.63 |
Rps27l |
ribosomal protein S27-like |
12084 |
0.15 |
chr2_56257440_56257969 | 21.58 |
Gm13518 |
predicted gene 13518 |
217851 |
0.02 |
chr16_52387159_52387325 | 21.36 |
Alcam |
activated leukocyte cell adhesion molecule |
65223 |
0.14 |
chr13_83739197_83739995 | 21.31 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr8_26677560_26678005 | 21.13 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chr5_20056465_20056826 | 21.12 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr13_83749857_83750036 | 20.98 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr1_20428787_20428938 | 20.96 |
Gm15795 |
predicted gene 15795 |
15948 |
0.17 |
chr16_63806441_63806811 | 20.87 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr4_21095762_21096024 | 20.66 |
Gm11871 |
predicted gene 11871 |
84953 |
0.1 |
chr16_63747767_63748162 | 20.47 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr10_70484969_70485278 | 20.45 |
Gm29783 |
predicted gene, 29783 |
20125 |
0.19 |
chr3_66102086_66102567 | 20.03 |
Gm36973 |
predicted gene, 36973 |
2521 |
0.19 |
chr10_19318275_19318532 | 19.99 |
Gm33056 |
predicted gene, 33056 |
27414 |
0.17 |
chr15_18190039_18190239 | 19.67 |
Gm8318 |
predicted gene 8318 |
26258 |
0.22 |
chr12_29789878_29790063 | 19.65 |
Myt1l |
myelin transcription factor 1-like |
50240 |
0.17 |
chr3_78792451_78792970 | 19.62 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr3_5326430_5327011 | 18.97 |
Zfhx4 |
zinc finger homeodomain 4 |
85048 |
0.09 |
chr1_67366568_67366878 | 18.92 |
Gm26342 |
predicted gene, 26342 |
109499 |
0.06 |
chr13_84783651_84783837 | 18.91 |
Gm26913 |
predicted gene, 26913 |
92803 |
0.09 |
chr2_132427639_132427949 | 18.84 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr13_58964694_58965094 | 18.77 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr2_70127967_70128143 | 18.54 |
Myo3b |
myosin IIIB |
31757 |
0.19 |
chr6_55484275_55484600 | 18.52 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
24201 |
0.19 |
chr13_84751597_84751791 | 18.46 |
Gm26913 |
predicted gene, 26913 |
60753 |
0.15 |
chr8_12126295_12126640 | 18.23 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr16_67610911_67611282 | 18.20 |
Cadm2 |
cell adhesion molecule 2 |
9397 |
0.25 |
chr7_74687903_74688273 | 18.18 |
Gm7726 |
predicted gene 7726 |
11768 |
0.26 |
chr8_31895464_31895660 | 18.17 |
Nrg1 |
neuregulin 1 |
8976 |
0.25 |
chr12_56458764_56459233 | 18.11 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr11_47069891_47070050 | 17.98 |
Gm12175 |
predicted gene 12175 |
195557 |
0.03 |
chr13_52457883_52458068 | 17.96 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr13_78324889_78325040 | 17.81 |
Gm3963 |
predicted gene 3963 |
37880 |
0.11 |
chr1_176099027_176099243 | 17.79 |
Gm38081 |
predicted gene, 38081 |
66412 |
0.1 |
chrX_61393166_61393371 | 17.73 |
Gm14665 |
predicted gene 14665 |
4241 |
0.3 |
chr2_41498351_41498548 | 17.66 |
Lrp1b |
low density lipoprotein-related protein 1B |
290629 |
0.01 |
chr5_107497898_107498054 | 17.62 |
Btbd8 |
BTB (POZ) domain containing 8 |
197 |
0.9 |
chr7_96865260_96865776 | 17.60 |
Gm25712 |
predicted gene, 25712 |
2139 |
0.28 |
chr1_81594178_81594459 | 17.50 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr17_56472537_56473329 | 17.37 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr12_33225655_33225815 | 17.29 |
Atxn7l1os1 |
ataxin 7-like 1, opposite strand 1 |
3119 |
0.29 |
chr8_86961518_86961711 | 17.18 |
Gm24781 |
predicted gene, 24781 |
4005 |
0.19 |
chr8_47642536_47642697 | 17.17 |
Gm8623 |
predicted gene 8623 |
9852 |
0.12 |
chr2_50971381_50971555 | 17.16 |
Gm13498 |
predicted gene 13498 |
61784 |
0.14 |
chr19_30160000_30160313 | 16.97 |
Rpl31-ps20 |
ribosomal protein L31, pseudogene 20 |
464 |
0.82 |
chr9_61102454_61102622 | 16.96 |
4933433G08Rik |
RIKEN cDNA 4933433G08 gene |
2847 |
0.2 |
chr6_61066614_61066949 | 16.90 |
Gm43893 |
predicted gene, 43893 |
2474 |
0.28 |
chr3_40673604_40673797 | 16.88 |
Intu |
inturned planar cell polarity protein |
1079 |
0.49 |
chr17_66869624_66870037 | 16.85 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr13_78580917_78581111 | 16.83 |
Gm48402 |
predicted gene, 48402 |
57003 |
0.14 |
chr12_50120116_50120285 | 16.81 |
Gm40418 |
predicted gene, 40418 |
109 |
0.98 |
chr3_18454033_18454237 | 16.75 |
Gm30667 |
predicted gene, 30667 |
7119 |
0.22 |
chr10_29143863_29144732 | 16.68 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr12_90131976_90132183 | 16.67 |
Gm48700 |
predicted gene, 48700 |
63980 |
0.15 |
chr12_47163286_47163464 | 16.66 |
Gm36971 |
predicted gene, 36971 |
1667 |
0.48 |
chr10_70458638_70458831 | 16.58 |
Fam13c |
family with sequence similarity 13, member C |
17808 |
0.19 |
chr12_47164101_47164307 | 16.53 |
Gm36971 |
predicted gene, 36971 |
838 |
0.72 |
chr1_46829988_46830169 | 16.48 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5821 |
0.22 |
chr8_90576969_90577137 | 16.47 |
Gm45639 |
predicted gene 45639 |
97905 |
0.07 |
chr11_28697993_28698421 | 16.45 |
2810471M01Rik |
RIKEN cDNA 2810471M01 gene |
16643 |
0.16 |
chr18_40059274_40059425 | 16.45 |
Gm50395 |
predicted gene, 50395 |
50384 |
0.16 |
chr16_91140532_91140860 | 16.25 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr3_50014297_50014449 | 16.16 |
Gm37854 |
predicted gene, 37854 |
12401 |
0.22 |
chr13_71507941_71508418 | 16.13 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr12_58670274_58670654 | 16.00 |
Gm18873 |
predicted gene, 18873 |
93442 |
0.08 |
chr16_43502947_43503194 | 15.91 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
544 |
0.83 |
chr5_116895407_116895611 | 15.85 |
Gm43122 |
predicted gene 43122 |
64955 |
0.1 |
chr11_41532495_41533004 | 15.80 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr5_84153090_84153587 | 15.77 |
Hmgn2-ps1 |
high mobility group nucleosomal binding domain 2, pseudogene 1 |
30025 |
0.25 |
chr1_168328003_168328211 | 15.74 |
Gm37524 |
predicted gene, 37524 |
9564 |
0.24 |
chr10_92097138_92097289 | 15.73 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
6576 |
0.22 |
chr19_59006658_59006882 | 15.70 |
Shtn1 |
shootin 1 |
31515 |
0.15 |
chr6_51767665_51767816 | 15.68 |
Gm38811 |
predicted gene, 38811 |
56659 |
0.13 |
chr18_27956389_27956743 | 15.60 |
Gm33674 |
predicted gene, 33674 |
146834 |
0.05 |
chr2_54265163_54265368 | 15.59 |
Gm14035 |
predicted gene 14035 |
18850 |
0.21 |
chrX_71700854_71701085 | 15.53 |
Gm14723 |
predicted gene 14723 |
26688 |
0.18 |
chr18_45014470_45014883 | 15.37 |
Gm31706 |
predicted gene, 31706 |
30186 |
0.16 |
chr8_87064278_87064454 | 15.30 |
Gm18602 |
predicted gene, 18602 |
12119 |
0.15 |
chr4_111004709_111005071 | 15.30 |
Agbl4 |
ATP/GTP binding protein-like 4 |
113951 |
0.07 |
chr1_159015364_159015547 | 15.28 |
Pappa2 |
pappalysin 2 |
34965 |
0.17 |
chr17_51536754_51537055 | 15.28 |
Gm31143 |
predicted gene, 31143 |
2046 |
0.39 |
chr10_46718838_46719012 | 15.26 |
Gm19994 |
predicted gene, 19994 |
48781 |
0.16 |
chr13_52562127_52562509 | 15.24 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr4_71933713_71933873 | 15.21 |
Gm11234 |
predicted gene 11234 |
46684 |
0.17 |
chr2_63669900_63670081 | 15.17 |
Gm23503 |
predicted gene, 23503 |
237796 |
0.02 |
chr7_64884497_64884825 | 15.15 |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
11664 |
0.22 |
chr7_117472401_117472742 | 15.11 |
Xylt1 |
xylosyltransferase 1 |
2921 |
0.39 |
chr1_42703489_42704501 | 15.11 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr13_83714747_83715651 | 15.08 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6182 |
0.14 |
chr13_95995367_95995681 | 15.05 |
Sv2c |
synaptic vesicle glycoprotein 2c |
5298 |
0.24 |
chr9_9263661_9263812 | 15.05 |
Gm16833 |
predicted gene, 16833 |
3053 |
0.29 |
chr7_79591873_79592800 | 14.99 |
Gm45169 |
predicted gene 45169 |
277 |
0.82 |
chr6_16316362_16316531 | 14.96 |
Gm3148 |
predicted gene 3148 |
78819 |
0.1 |
chr12_44839950_44840386 | 14.92 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr2_41093986_41094158 | 14.90 |
Gm13460 |
predicted gene 13460 |
95215 |
0.09 |
chr1_4970686_4970886 | 14.87 |
Gm16041 |
predicted gene 16041 |
71 |
0.97 |
chr18_81831298_81831489 | 14.86 |
Gm30454 |
predicted gene, 30454 |
18623 |
0.19 |
chr14_35112923_35113111 | 14.85 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr1_157969609_157969781 | 14.85 |
Gm38256 |
predicted gene, 38256 |
29310 |
0.25 |
chr2_141955236_141955408 | 14.82 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
116533 |
0.07 |
chr8_30924151_30924556 | 14.80 |
Gm45252 |
predicted gene 45252 |
79555 |
0.1 |
chr1_41605488_41605642 | 14.78 |
Gm28634 |
predicted gene 28634 |
76022 |
0.12 |
chr8_34326259_34326892 | 14.77 |
Gm4889 |
predicted gene 4889 |
1335 |
0.32 |
chr4_32325733_32325955 | 14.73 |
Bach2it1 |
BTB and CNC homology 2, intronic transcript 1 |
74083 |
0.1 |
chr8_41054736_41055125 | 14.73 |
Mtus1 |
mitochondrial tumor suppressor 1 |
136 |
0.94 |
chr10_33624726_33624916 | 14.72 |
Clvs2 |
clavesin 2 |
52 |
0.9 |
chr6_12117902_12118084 | 14.68 |
Gm6578 |
predicted gene 6578 |
8410 |
0.23 |
chr18_78455374_78455574 | 14.67 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21404 |
0.24 |
chr12_12684520_12684723 | 14.67 |
Gm27952 |
predicted gene, 27952 |
2003 |
0.29 |
chr12_33035439_33035619 | 14.65 |
Cdhr3 |
cadherin-related family member 3 |
17457 |
0.14 |
chr3_47668909_47669138 | 14.61 |
Gm2229 |
predicted gene 2229 |
208685 |
0.03 |
chr14_85508520_85508926 | 14.55 |
Gm9264 |
predicted gene 9264 |
29697 |
0.26 |
chr2_181766899_181767258 | 14.55 |
Myt1 |
myelin transcription factor 1 |
36 |
0.97 |
chr8_49243134_49243285 | 14.53 |
Gm45832 |
predicted gene 45832 |
11240 |
0.28 |
chr17_84749518_84749672 | 14.52 |
Lrpprc |
leucine-rich PPR-motif containing |
1667 |
0.35 |
chr4_20401022_20401283 | 14.50 |
Gm11873 |
predicted gene 11873 |
10056 |
0.28 |
chr15_85463386_85463550 | 14.49 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
39759 |
0.14 |
chr4_71230174_71230407 | 14.44 |
Gm11229 |
predicted gene 11229 |
55652 |
0.15 |
chr6_15397521_15397861 | 14.44 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr17_8368820_8369004 | 14.44 |
T2 |
brachyury 2 |
3484 |
0.15 |
chr5_36174716_36175143 | 14.42 |
Psapl1 |
prosaposin-like 1 |
29092 |
0.21 |
chr5_4812167_4812377 | 14.42 |
Gm44483 |
predicted gene, 44483 |
9815 |
0.12 |
chr4_21665942_21666298 | 14.40 |
Gm11876 |
predicted gene 11876 |
4920 |
0.2 |
chr11_11014435_11014603 | 14.35 |
Vwc2 |
von Willebrand factor C domain containing 2 |
99704 |
0.08 |
chr2_41471881_41472032 | 14.29 |
Lrp1b |
low density lipoprotein-related protein 1B |
317122 |
0.01 |
chrX_47124254_47124450 | 14.27 |
Gm14609 |
predicted gene 14609 |
256982 |
0.02 |
chr15_37787189_37787357 | 14.25 |
Ncald |
neurocalcin delta |
4727 |
0.2 |
chr12_37978926_37979077 | 14.24 |
Dgkb |
diacylglycerol kinase, beta |
38713 |
0.17 |
chr1_138500251_138500631 | 14.24 |
Gm28501 |
predicted gene 28501 |
15174 |
0.2 |
chr9_23378360_23378672 | 14.24 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr2_93957909_93958083 | 14.24 |
Gm13889 |
predicted gene 13889 |
795 |
0.55 |
chrX_60545622_60545821 | 14.22 |
Gm715 |
predicted gene 715 |
2298 |
0.23 |
chr5_81359614_81359973 | 14.21 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
49768 |
0.18 |
chr2_21270050_21270364 | 14.20 |
Gm13378 |
predicted gene 13378 |
26102 |
0.17 |
chr18_23036938_23037296 | 14.17 |
Nol4 |
nucleolar protein 4 |
1539 |
0.55 |
chr16_67175484_67175665 | 14.17 |
Gm49640 |
predicted gene, 49640 |
62776 |
0.16 |
chr13_63985759_63985962 | 14.11 |
Gm7695 |
predicted gene 7695 |
39339 |
0.14 |
chrX_42343522_42343895 | 14.11 |
Gm14619 |
predicted gene 14619 |
3804 |
0.34 |
chr13_20609106_20609281 | 14.10 |
Gm47721 |
predicted gene, 47721 |
36564 |
0.17 |
chr9_37114956_37115270 | 14.07 |
Gm48716 |
predicted gene, 48716 |
3543 |
0.18 |
chr14_77406295_77406469 | 14.06 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
25736 |
0.17 |
chr16_59854456_59854822 | 14.05 |
Epha6 |
Eph receptor A6 |
151082 |
0.04 |
chr18_25548818_25548982 | 13.97 |
Celf4 |
CUGBP, Elav-like family member 4 |
47661 |
0.16 |
chr1_179106714_179107112 | 13.92 |
Smyd3 |
SET and MYND domain containing 3 |
117568 |
0.06 |
chr13_76810564_76810975 | 13.89 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
14438 |
0.26 |
chr1_74103754_74104304 | 13.89 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr10_66546751_66546933 | 13.87 |
Gm22594 |
predicted gene, 22594 |
63289 |
0.12 |
chr13_78181182_78181614 | 13.81 |
Gm38604 |
predicted gene, 38604 |
1761 |
0.26 |
chr11_32019966_32020621 | 13.79 |
Nsg2 |
neuron specific gene family member 2 |
19791 |
0.19 |
chr5_133821082_133821288 | 13.79 |
Gm7902 |
predicted gene 7902 |
21334 |
0.25 |
chr3_26145444_26145600 | 13.79 |
Nlgn1 |
neuroligin 1 |
7785 |
0.32 |
chr4_148327377_148327851 | 13.75 |
Gm13206 |
predicted gene 13206 |
20761 |
0.14 |
chr7_76789063_76789214 | 13.74 |
Gm45210 |
predicted gene 45210 |
89421 |
0.1 |
chr4_70811006_70811333 | 13.73 |
Gm11227 |
predicted gene 11227 |
261504 |
0.02 |
chr2_101979368_101979730 | 13.72 |
Gm13919 |
predicted gene 13919 |
60080 |
0.11 |
chr15_74194149_74194481 | 13.72 |
Gm15387 |
predicted gene 15387 |
99982 |
0.07 |
chr11_26437833_26438032 | 13.67 |
Gm12713 |
predicted gene 12713 |
28725 |
0.18 |
chr13_26657396_26657590 | 13.61 |
Gm47883 |
predicted gene, 47883 |
23200 |
0.23 |
chr17_88764144_88764434 | 13.57 |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
9767 |
0.24 |
chr9_41378019_41378386 | 13.55 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1641 |
0.36 |
chr19_21781727_21782179 | 13.55 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
3565 |
0.26 |
chr2_142362908_142363300 | 13.54 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
186497 |
0.03 |
chr10_43106136_43106524 | 13.54 |
Gm29245 |
predicted gene 29245 |
47886 |
0.11 |
chr5_9339805_9340127 | 13.53 |
Gm15733 |
predicted gene 15733 |
13793 |
0.19 |
chr10_87501180_87501623 | 13.51 |
Gm48120 |
predicted gene, 48120 |
6461 |
0.19 |
chr2_57523169_57523407 | 13.50 |
Gm13531 |
predicted gene 13531 |
97579 |
0.07 |
chr3_30153909_30154137 | 13.49 |
Gm38066 |
predicted gene, 38066 |
7863 |
0.21 |
chr3_83985537_83985711 | 13.48 |
Tmem131l |
transmembrane 131 like |
17396 |
0.24 |
chr5_106577659_106577832 | 13.47 |
Gm29464 |
predicted gene 29464 |
2870 |
0.18 |
chr17_63807674_63808197 | 13.46 |
Fer |
fer (fms/fps related) protein kinase |
55127 |
0.13 |
chr12_77991634_77991958 | 13.43 |
Gm8219 |
predicted gene 8219 |
172214 |
0.03 |
chr4_111686063_111686242 | 13.41 |
Spata6 |
spermatogenesis associated 6 |
33832 |
0.2 |
chrX_130820134_130820324 | 13.36 |
Gm26209 |
predicted gene, 26209 |
67549 |
0.13 |
chr6_111844651_111844869 | 13.30 |
Gm22093 |
predicted gene, 22093 |
241508 |
0.02 |
chr4_54329031_54329272 | 13.29 |
Gm12469 |
predicted gene 12469 |
93275 |
0.09 |
chr14_75236389_75236560 | 13.28 |
Cpb2 |
carboxypeptidase B2 (plasma) |
5813 |
0.15 |
chr1_52079807_52079978 | 13.27 |
Gm28177 |
predicted gene 28177 |
2631 |
0.2 |
chr11_88240584_88240997 | 13.27 |
Gm38534 |
predicted gene, 38534 |
12578 |
0.16 |
chr7_96595597_96595770 | 13.23 |
Gm15414 |
predicted gene 15414 |
33386 |
0.19 |
chr3_127652402_127652663 | 13.16 |
Neurog2 |
neurogenin 2 |
19397 |
0.11 |
chr14_22679666_22680655 | 13.14 |
Lrmda |
leucine rich melanocyte differentiation associated |
83647 |
0.09 |
chr6_137699415_137699798 | 13.13 |
Strap |
serine/threonine kinase receptor associated protein |
35472 |
0.16 |
chr15_84531439_84531771 | 13.12 |
Rtl6 |
retrotransposon Gag like 6 |
26218 |
0.18 |
chr5_45008044_45008269 | 13.12 |
Gm10205 |
predicted gene 10205 |
23914 |
0.2 |
chr5_103335878_103336033 | 13.12 |
Gm42619 |
predicted gene 42619 |
8017 |
0.16 |
chr1_3094927_3095127 | 13.12 |
Gm26206 |
predicted gene, 26206 |
6989 |
0.25 |
chr2_72426764_72427187 | 13.04 |
Cdca7 |
cell division cycle associated 7 |
49184 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 23.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
6.8 | 27.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
6.6 | 19.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
5.0 | 15.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.8 | 4.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
4.6 | 18.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.0 | 12.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.6 | 25.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.3 | 9.9 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.1 | 3.1 | GO:0048880 | sensory system development(GO:0048880) |
3.0 | 33.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
3.0 | 18.1 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.9 | 8.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.8 | 8.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.8 | 8.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.7 | 8.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.7 | 8.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.6 | 23.3 | GO:0050957 | equilibrioception(GO:0050957) |
2.6 | 7.8 | GO:0007412 | axon target recognition(GO:0007412) |
2.4 | 21.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.4 | 7.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.3 | 16.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 4.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.2 | 8.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
2.1 | 6.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.1 | 10.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.1 | 6.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.0 | 6.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
2.0 | 7.8 | GO:0046959 | habituation(GO:0046959) |
2.0 | 7.8 | GO:0030091 | protein repair(GO:0030091) |
1.9 | 7.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.9 | 9.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.9 | 5.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.9 | 3.8 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
1.9 | 3.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.9 | 15.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.9 | 1.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.9 | 5.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.8 | 5.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.8 | 5.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.8 | 7.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.8 | 5.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.8 | 7.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.7 | 10.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.7 | 6.8 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
1.7 | 3.3 | GO:0031223 | auditory behavior(GO:0031223) |
1.7 | 5.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.6 | 6.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.6 | 1.6 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
1.6 | 8.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.6 | 4.7 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
1.6 | 6.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.6 | 7.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.5 | 21.4 | GO:0003334 | keratinocyte development(GO:0003334) |
1.5 | 6.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.5 | 7.5 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
1.5 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.5 | 4.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.5 | 7.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.5 | 5.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.5 | 7.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.4 | 26.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.4 | 24.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.4 | 6.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.4 | 4.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.3 | 4.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.3 | 2.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.3 | 2.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 2.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.3 | 2.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.3 | 3.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.3 | 3.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.2 | 3.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 8.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.2 | 15.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.2 | 1.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.2 | 3.5 | GO:0006562 | proline catabolic process(GO:0006562) |
1.2 | 5.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.2 | 3.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 5.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.1 | 3.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.1 | 5.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 6.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 3.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.1 | 3.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 5.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.1 | 3.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 4.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 3.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.1 | 3.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.1 | 3.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.0 | 2.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 3.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.0 | 11.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.0 | 2.0 | GO:0060618 | nipple development(GO:0060618) |
1.0 | 6.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 5.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 4.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.0 | 4.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 2.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 2.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.0 | 1.9 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.9 | 1.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.9 | 4.7 | GO:0014028 | notochord formation(GO:0014028) |
0.9 | 3.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 4.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.9 | 2.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.9 | 1.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 6.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.9 | 4.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.9 | 2.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 2.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.9 | 7.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.9 | 2.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.9 | 3.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.9 | 6.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 2.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 6.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 2.5 | GO:0008355 | olfactory learning(GO:0008355) |
0.8 | 10.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.8 | 2.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 2.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.8 | 2.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 5.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.8 | 0.8 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.8 | 3.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 2.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 1.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 4.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.8 | 8.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 1.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.8 | 2.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 0.8 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 2.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.8 | 3.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 2.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 3.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 3.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.7 | 6.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 5.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.7 | 2.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.7 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.7 | 3.7 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.7 | 2.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 2.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 6.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.7 | 2.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 3.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 1.4 | GO:1903367 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.7 | 1.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.7 | 12.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.7 | 2.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 3.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.7 | 1.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.7 | 3.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 2.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 5.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.7 | 2.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 4.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 5.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 2.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 2.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.7 | 2.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 1.9 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.6 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 5.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 3.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 1.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 6.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.6 | 1.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 3.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 2.5 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 1.2 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.6 | 1.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 0.6 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.6 | 1.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 1.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.6 | 1.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 1.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 1.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.6 | 4.7 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.6 | 4.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.6 | 2.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 2.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 7.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.6 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 11.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 3.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.6 | 1.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.6 | 1.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 7.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 5.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 0.6 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 1.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 0.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 3.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 1.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 3.2 | GO:0060581 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.5 | 40.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 4.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.5 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 5.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 7.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.5 | 1.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 0.5 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 1.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.5 | 5.5 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 2.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 8.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 4.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 1.9 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 2.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 1.8 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 1.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 5.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 0.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 0.9 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.5 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 1.4 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 1.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.4 | 2.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 2.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 1.8 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 1.3 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 1.7 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.4 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 1.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 1.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.4 | 3.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 0.8 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.4 | 1.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.4 | 0.4 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.4 | 0.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 2.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 1.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 3.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 17.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 4.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 1.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 1.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 2.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.4 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 1.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 2.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 7.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 1.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.4 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 1.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 1.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.3 | 3.1 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 4.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 2.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 1.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.7 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 2.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.3 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) |
0.3 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 3.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 0.6 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.3 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.9 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.9 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.3 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 0.9 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.3 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 0.9 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.3 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 6.9 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.3 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 4.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 1.9 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 4.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.3 | 2.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.3 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 3.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.5 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.3 | 1.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.3 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 1.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 2.0 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 1.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 2.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 2.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 1.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) |
0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 2.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.8 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 1.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.8 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 2.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 2.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 1.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 3.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 2.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 3.6 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) eye photoreceptor cell development(GO:0042462) |
0.2 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 1.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.2 | 1.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 2.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 1.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.5 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 2.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.2 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.5 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.4 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 1.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.1 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.2 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 1.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 6.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 1.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 1.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 3.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 2.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.6 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 2.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 1.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:1904833 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.4 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.9 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 1.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 1.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 1.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 1.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.3 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.8 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.1 | 1.3 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.2 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 1.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 3.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 1.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.2 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.5 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.0 | GO:2000619 | regulation of histone H4-K16 acetylation(GO:2000618) negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 1.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.1 | GO:0003181 | atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 1.8 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.3 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.0 | 0.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.3 | 11.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.0 | 7.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.9 | 18.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 5.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.8 | 27.2 | GO:0043196 | varicosity(GO:0043196) |
1.8 | 10.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.6 | 47.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.6 | 8.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.4 | 5.6 | GO:0033010 | paranodal junction(GO:0033010) |
1.2 | 33.3 | GO:0044295 | axonal growth cone(GO:0044295) |
1.1 | 4.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 3.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.0 | 11.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.0 | 2.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.0 | 5.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 25.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 5.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.9 | 3.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 0.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.9 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 2.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 6.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 9.2 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.7 | 8.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 23.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 2.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 6.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 5.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 2.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 2.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.5 | 5.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 6.4 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 4.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 31.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 2.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 2.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 7.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 1.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 10.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 5.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 4.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 1.8 | GO:0051286 | cell tip(GO:0051286) |
0.5 | 3.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 2.2 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 6.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 6.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 3.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 3.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 4.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 54.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 1.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 3.4 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 7.3 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.4 | GO:0097433 | dense body(GO:0097433) |
0.3 | 1.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 2.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 6.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 22.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 2.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 3.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 3.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 12.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 10.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 1.9 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 19.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 2.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 4.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 3.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.6 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 5.4 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.4 | 43.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.6 | 19.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
6.0 | 30.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.3 | 10.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.3 | 12.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.3 | 9.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
3.2 | 12.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.2 | 12.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.9 | 8.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.6 | 7.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.9 | 5.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.9 | 5.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.9 | 13.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.8 | 5.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.8 | 7.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 5.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.7 | 8.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.7 | 5.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.5 | 7.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.5 | 4.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.4 | 4.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.4 | 9.6 | GO:0046790 | virion binding(GO:0046790) |
1.3 | 5.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.3 | 5.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 7.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.2 | 4.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 5.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.1 | 6.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 23.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 3.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.0 | 8.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 5.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.0 | 7.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 12.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.0 | 2.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.9 | 2.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 3.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 3.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.9 | 0.9 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.9 | 16.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.9 | 8.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.9 | 2.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 3.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 1.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 2.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 1.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 4.1 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 5.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.8 | 2.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 2.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 4.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 12.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 2.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.8 | 1.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 3.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 14.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 2.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 2.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.7 | 2.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 3.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.7 | 8.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 2.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 2.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 2.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 3.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 7.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.6 | 12.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 3.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 2.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 3.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 1.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 7.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.6 | 5.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.6 | 1.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 1.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 1.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 3.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 4.9 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.5 | 3.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 2.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 1.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 2.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 4.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 11.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 9.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 10.5 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 1.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 5.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 2.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.3 | GO:0046428 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 5.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 2.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 2.8 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 4.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 7.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 3.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 4.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 2.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 0.3 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.3 | 3.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 6.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 5.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 2.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 0.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 1.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 5.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.9 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 1.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 6.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 3.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 5.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 3.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 14.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 5.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 3.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 3.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 2.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.6 | GO:0043823 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 2.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 2.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 2.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.9 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.6 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 0.9 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 3.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.7 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.2 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 4.4 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 2.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 3.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 3.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 2.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 3.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 2.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 4.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.4 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.3 | 40.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 15.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 1.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 2.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 5.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 3.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 6.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 6.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 7.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 4.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 8.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.4 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 3.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 6.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 3.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.4 | 1.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.2 | 9.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 11.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 27.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 14.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 6.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.9 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.8 | 16.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 7.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 19.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 11.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 10.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 7.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 9.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 11.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 10.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 8.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 7.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 16.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 3.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 1.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 12.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 4.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 7.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 4.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 5.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.2 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 1.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |